CorMedix Inc.

Published in Genome Research and led by King’s College London, the Human Gut Microbiome Atlas identifies gut bacteria appearing in individuals with 23 separate diseases across 19 countries. It was c

By a matter of minutes, Evive Biotech ’s long-delayed long-acting G-CSF Ryzneuta (efbemalenograstim alfa-vuxw) became the 50th novel agent approved in 2023 by the US FDA’s Center for Drug Evaluation

Takeda Pharmaceutical Co. Ltd. is looking forward to US FDA action on two novel agents during the month of November. If they are both approvals, they could provide welcome new storylines after the co

A beneficial effect of sponsorship by the largest companies in the pharma industry can be seen in the fates of novel agent applications that faced US FDA approval decisions in recent years: the applic